Ivermectin Toxicity in Young Mice

Laboratory Animal Science

Volumn 46, Issue 1, 1996, Pages 111-112

  Skopets, Boris ^a   Wilson, Ronald P ^a   Griffith, James W ^a   Max Lang, C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG TOXICITY; EXPERIMENTAL ANIMAL; MITE; MOUSE; NONHUMAN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGE FACTORS; ANIMALS; ANIMALS, LABORATORY; FEMALE; HYPOTHERMIA; INSECTICIDES; IVERMECTIN; MALE; MICE; MICE, INBRED STRAINS; MITE INFESTATIONS; RODENT DISEASES; SEIZURES; TREMOR;

EID: 0029971219     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Constantin, M. L. 1972. Effects of insecticides on acariasis in mice. Lab. Animals 6:279-286.
2. Weisbroth, S. 1982. Arthropods, vol. 2, p. 390-402. In H. L Foster, J. D. Small, and J. G. Fox (ed.), The mouse in biomedical research. Academic Press, Inc., New York.
3. Bean-Knudsen, D. E., J. E. Wagner, and R. D. Hall. 1986. Evaluation of the control of Myobia musculi infestations on laboratory mice with permethrin. Lab. Anim. Sei. 36:268-270
4. Baumans, V., R. Havenaar, H. Van Herck, et al. 1988. The effectiveness of Ivomec and Neguvon in the control of murine mites Lab. Animals 22:243-245.
5. Pappini, R., and A. Marconcini. 1991. Treatment with ivermectin in drinking water against Myobia musculi and Myocoptes musculinus mange in naturally infected laboratory mice. Angew. Parasitol. 32:11-13.
6. Pence, B. C., D. S. Demick, B. C. Richard, et al. 1991. The efficacy and safety of chlorpyrifos (Dursban) for control of Myobia musculi infestation in mice. Lab. Anim. Sci. 41:139-142.
7. Le Blanc, S. A., R. E. Faith, and C. A. Montgomery. 1993. Use of topical ivermectin treatment for Syphacia abvelata in mice. Lab. Anim. Sci. 43:526-528.
8. Lipman, N. S., S. D. Dalton, A. R. Stuart, et al. 1994. Eradication of pinworms (Syphacia obvelata) from a large mouse breeding colony by combination oral anthelmintic therapy. Lab. Anim. Sci 44:517-520.
9. Lovell, R. A. 1990. Ivermectin and piperazine toxicoses in dogs and cats. Vet. Clin. North Am. Small Anim. Pract. 20:453-468.
10. Lankas, G. R., D. H. Minsker, and R. T. Robertson. 1989. Effects of ivermectin on reproduction and neonatal toxicity in rats. Food Chem. Toxicol. 27:523-529.
11. Lankas, G. R., and L. R. Gordon. 1989. Toxicology, p. 89-113. In W. C. Campbell (ed.), Ivermectin and abamectin. Springer-Verlag, New York.
12. Risau, W., and H. Wolburg. 1990. Development of the bloodbrain barrier. Trends Neurosci. 13:174-178.
13. Beta, A. L., and G. W. Goldstein. 1981. Developmental changes of metabolism and transport properties of capillaries isolated from rat brain. J. Physiol. 312:365-376
14. Goldstein, G. W., and A. L. Betz. 1986. The blood-brain barrier. Sci. Am. 255:70-79.
15. Bauer, H. C., H. Bauer, A. Lametschwandtner, et al. 1993. Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res. Dev Brain Res. 75:269-278.
16. Schinkel, A. H., J. J. M. Smit, O. van Tellingen, et al. 1994. Disruption of the mouse mdr 1a P-glucoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.